Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: d


Summaries of Product Characteristics 1 - 30 of 280
  1  2  3  4  5  6  7  8  9  10  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti/itsehoito

D-Calsor 500 mg-10 mikrog (400 IU), 500 mg-20 mikrog(800IU) tabletti, kalvopäällysteinen SPC 2020-10-29

PL

Resepti

Dacarbazine Lipomed 200 mg injektio-infuusiokuiva-aine-liuosta varten SPC 2021-07-27

PL

Resepti

Dacarbazine Lipomed 500 mg, 1000 mg infuusiokuiva-aine, liuosta varten SPC 2022-04-07

PL

Resepti

Dacarbazine medac 100 mg, 200 mg, 500 mg, 1000 mg injektio-infuusiokuiva-aine liuosta varten SPC 2022-04-26

PL

Resepti

Dacarbazine medac 100 mg, 200 mg, 500 mg, 1000 mg injektio-infuusiokuiva-aine liuosta varten SPC 2024-04-26

PL

Resepti

Dacepton 10 mg-ml injektioneste SPC 2022-02-03 Uusi

PL

Resepti

Dacepton 5 mg-ml infuusioneste SPC 2021-05-21

European Medicines Agency's website:
Dacogen - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Dafiro - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Dafiro HCT - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Dailiport 0,5 mg, 1 mg, 2 mg, 3 mg, 5 mg depotkapseli, kova SPC 2022-06-13 Uusi

PL

Resepti

Daisynelle 150 mikrog -20 mikrog ja 150 mikrog-30 mikrog tabletti SPC 2022-05-23

PL

Resepti

Daivobet 50-500 mikrog-g geeli SPC 2021-12-27

PL

Resepti

Daivobet 50-500 mikrog-g voide SPC 2021-12-27

European Medicines Agency's website:
Daklinza - EMA: EPAR PI
Finnish Swedish

PL

Itsehoito

Daktacort emulsiovoide SPC 2021-09-01

PL

Itsehoito

Daktarin 2 prosenttia puuteri SPC 2021-09-01

PL

Itsehoito

Daktarin 2 prosenttinen emulsiovoide SPC 2021-09-01

PL

Resepti

Dalacin 10 mg-ml emulsio iholle SPC 2021-08-25

PL

Resepti

Dalacin 100mg emätinpuikko SPC 2021-07-01

PL

Resepti

DALACIN 15 mg-ml rakeet oraaliliuosta varten SPC 2021-12-22

PL

Resepti

Dalacin 150 mg, 300 mg kapseli SPC 2021-10-20

PL

Resepti

Dalacin 2 prosenttinen emätinemulsiovoide, SPC 2021-06-29

PL

Resepti

Daptomycin Accordpharma 350 mg, 500 mg injektio-infuusiokuiva-aine, liuosta varten SPC 2019-11-21

PL

Resepti

Daptomycin BE Pharma 350 mg, 500 mg injektio-infuusiokuiva-aine, liuosta varten SPC 2021-03-23.docx

European Medicines Agency's website:
Daptomycin Hospira - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Daptomycin Norameda 350 mg injektio-infuusiokuiva-aine liuosta varten SPC 2022-06-06

PL

Resepti

Daptomycin Norameda 500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2022-06-06

PL

Resepti

Daptomycin Reddy 350 mg, 500 mg injektio-infuusiokuiva-aine liuosta varten SPC 2020-08-19

PL

Resepti

Darunavir Accord 400 mg, 800 mg tabletti, kalvopäällysteinen SPC 2020-01-21

  1  2  3  4  5  6  7  8  9  10  |  Next 30   >